Polygenic risk score, psychosocial environment and the risk of attention-deficit/hyperactivity disorder
- PMID: 33009369
- PMCID: PMC7532146
- DOI: 10.1038/s41398-020-01019-6
Polygenic risk score, psychosocial environment and the risk of attention-deficit/hyperactivity disorder
Abstract
The objective of the present study was to investigate whether the polygenic liability for attention-deficit/hyperactivity disorder (ADHD) and the psychosocial environment impact the risk of ADHD in interaction or independently of each other. We conducted a register- and biobank-based cohort study of 13,725 individuals with ADHD and 20,147 randomly drawn population-based controls. These 33,872 cohort members were genotyped on the Infinium PsychChip v1.0 array (Illumina). Subsequently, we calculated the polygenic risk score (PRS) for ADHD and extracted register data regarding the following risk factors pertaining to the psychosocial environment for each cohort member at the time of birth: maternal/paternal history of mental disorders, maternal/paternal education, maternal/paternal work status, and maternal/paternal income. We used logistic regression analyses to assess the main effects of the PRS for ADHD and the psychosocial environment on the risk of ADHD. Subsequently, we evaluated whether the effect of the PRS and the psychosocial environment act independently or in interaction upon the risk of ADHD. We found that ADHD was strongly associated with the PRS (odds ratio: 6.03, 95%CI: 4.74-7.70 for highest vs. lowest 2% liability). All risk factors pertaining to the psychosocial environment were associated with an increased risk of ADHD. These associations were only slightly attenuated after mutual adjustments. We found no statistically significant interaction between the polygenic liability and the psychosocial environment upon the risk of ADHD. In conclusion, we found main effects of both polygenic liability and risk factors pertaining to the psychosocial environment on the risk of ADHD-in the expected direction.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures



Similar articles
-
Genetic liability to ADHD and substance use disorders in individuals with ADHD.Addiction. 2020 Jul;115(7):1368-1377. doi: 10.1111/add.14910. Epub 2020 Jan 8. Addiction. 2020. PMID: 31803957
-
Interplay of ADHD Polygenic Liability With Birth-Related, Somatic, and Psychosocial Factors in ADHD: A Nationwide Study.Am J Psychiatry. 2023 Jan 1;180(1):73-88. doi: 10.1176/appi.ajp.21111105. Epub 2022 Sep 7. Am J Psychiatry. 2023. PMID: 36069019
-
Polygenic Risk and the Course of Attention-Deficit/Hyperactivity Disorder From Childhood to Young Adulthood: Findings From a Nationally Representative Cohort.J Am Acad Child Adolesc Psychiatry. 2021 Sep;60(9):1147-1156. doi: 10.1016/j.jaac.2020.12.033. Epub 2021 Jan 10. J Am Acad Child Adolesc Psychiatry. 2021. PMID: 33440202 Free PMC article.
-
Genetic and psychosocial influence on the association between early childhood infections and later psychiatric disorders.Acta Psychiatr Scand. 2022 Nov;146(5):406-419. doi: 10.1111/acps.13491. Epub 2022 Sep 8. Acta Psychiatr Scand. 2022. PMID: 35999619 Free PMC article.
-
Systematic Review: How the Attention-Deficit/Hyperactivity Disorder Polygenic Risk Score Adds to Our Understanding of ADHD and Associated Traits.J Am Acad Child Adolesc Psychiatry. 2021 Oct;60(10):1234-1277. doi: 10.1016/j.jaac.2021.01.019. Epub 2021 Feb 4. J Am Acad Child Adolesc Psychiatry. 2021. PMID: 33548493 Free PMC article.
Cited by
-
Youth Polygenic Scores, Youth ADHD Symptoms, and Parenting Dimensions: An Evocative Gene-Environment Correlation Study.Res Child Adolesc Psychopathol. 2023 May;51(5):665-677. doi: 10.1007/s10802-023-01024-5. Epub 2023 Jan 16. Res Child Adolesc Psychopathol. 2023. PMID: 36645612 Free PMC article.
-
Research Review: A review of the past decade of family and genomic studies on adolescent mental health.J Child Psychol Psychiatry. 2025 Jun;66(6):910-927. doi: 10.1111/jcpp.14099. Epub 2024 Dec 19. J Child Psychol Psychiatry. 2025. PMID: 39697100 Free PMC article. Review.
-
Gene - maltreatment interplay in adult ADHD symptoms: main role of a gene-environment correlation effect in a Brazilian population longitudinal study.Mol Psychiatry. 2024 Nov;29(11):3412-3421. doi: 10.1038/s41380-024-02589-3. Epub 2024 May 14. Mol Psychiatry. 2024. PMID: 38744991
-
Hippocampal dentate gyri proteomics reveals Wnt signaling involvement in the behavioral impairment in the THRSP-overexpressing ADHD mouse model.Commun Biol. 2023 Jan 16;6(1):55. doi: 10.1038/s42003-022-04387-5. Commun Biol. 2023. PMID: 36646879 Free PMC article.
-
Increasing specificity in ADHD genetic association studies during childhood: use of the oxytocin-vasopressin pathway in attentional processes suggests specific mechanism for endophenotypes in the 2004 Pelotas birth (Brazil) cohort.Eur Arch Psychiatry Clin Neurosci. 2025 Feb 11. doi: 10.1007/s00406-025-01968-3. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2025. PMID: 39934319
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. (American Psychiatric Association, Washington, DC. 2013).
-
- Ostergaard SD, Dalsgaard S, Faraone SV, Munk-Olsen T, Laursen TM. Teenage parenthood and birth rates for individuals with and without attention-deficit/hyperactivity disorder: a nationwide cohort study. J. Am. Acad. Child Adolesc. Psychiatry. 2017;56:578–584.e573. doi: 10.1016/j.jaac.2017.05.003. - DOI - PubMed
-
- Dalsgaard S, Ostergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015;2:702–709. - PubMed
Publication types
MeSH terms
Grants and funding
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
- R165-2013-15320, R102-A9118, R155-2014-1724 and R248-2017-2003/Lundbeckfonden (Lundbeck Foundation)/International
LinkOut - more resources
Full Text Sources
Medical